Live Breaking News & Updates on Ovishield vaccine

Stay informed with the latest breaking news from Ovishield vaccine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ovishield vaccine and stay connected to the pulse of your community

Sputnik V vaccine to be available in Delhi after June 20: CM Kejriwal

New Delhi [India], May 31 (ANI): Russian vaccine 'Sputnik V' will soon be available in Delhi with the Chief Minister Arvind Kejriwal on Monday said that the makers of the vaccine has assured to send a consignment to the national capital after June 20.

Yahoo , Arvind-kejriwal , Ussian-vaccine , Ew-delhi , Ni , Ovishield-vaccine , Ndia , Accine , யாகூ , அரவிந்த்-கேஜ்றிவாள் , நி

Delhi receives 1.5 lakh Covishield doses for 45+ category, Covaxin stock exhausted

Aam Aadmi Party (AAP) MLA Atishi Marlena has informed that Delhi on Monday received nearly 1.5 lakh doses of Covishield for the 45 plus age group and that Covaxin's stock for this category is about to finish. She said that a total of 68,946 doses were administered in the city on Saturday and Sunday.

Delhi , India , Bharat , Atishi-marlena , Manish-sisodia , Pfizer , Aam-aadmi-party , Johnson , Image-source , Aadmi-party , Bharat-biotech , Deputy-chief-minister-manish-sisodia

500 vials of Covishield missing from Hyderabad hospital

URL copied
500 vials of Covishield missing from Hyderabad hospital (Representational Image)
A total of 500 Covishield vials have been reported missing from a government hospital in Hyderabad, police said on Friday. The medical superintendent of the hospital at Kondapur has lodged a complaint that 50 boxes containing 500 Covishield vaccines have gone missing, the police said.
The boxes were found missing when the superintendent asked one of his colleagues to check the stock on May 19, they said.
While examining CCTV footage, the police said they saw one of the hospital staff suspiciously moving in the refrigerated room.
Further investigation is on, the police said.

Hyderabad , Andhra-pradesh , India , Kondapur , Image-source , Representational-image , Covishield-vials-missing , Ovishield-missing-from-hyderabad-hospital , Ovishield , Yderabad-hospital , Ovishield-vaccine

CDSCO approves antibody cocktail drug for restricted emergency use to treat mild Covid-19 cases

CDSCO approves antibody cocktail drug for restricted emergency use to treat mild Covid-19 cases
CDSCO approves use of antibodies cocktail drug (Casirivimab and Imdevimab) for restricted emergency use to treat mild to moderate Covid-19 in adults and paediatric patients.
advertisement
Health workers inspect Covid-19 patients at a hospital in New Delhi. (Photo credit: PTI).
The Indian regulatory body, Central Drugs Standards Control Organisation (CDSCO), has approved the use of antibodies cocktail drug (Casirivimab and Imdevimab), for restricted emergency used to treat mild to moderate Covid-19 in adults and paediatric patients (12 years or weighing more than at least 40 kg).
Antibodies Cocktail Drug can be a game-changer in Covid-19 treatment, especially when these are recommended to be given at the early stages of laboratory-confirmed SARS-CoV-2 infection positive result. Theis is preferebly administered within 10 days of symptoms onset.

Central-drugs-standards-control-organisation , Cocktail-drug , Covid-19 , Oche , Mergency-drug , Pproval-coronavirus-vaccine-india , Ovid-vaccine , Oronavirus-vaccine-update , Accine-in-india , Orona-vaccine , Oronavirus-vaccine-news

Bleeding, clotting events post COVID vaccination 'minuscule' in India: Govt panel

Bleeding, clotting events post COVID vaccination 'minuscule' in India: Govt panel - India has reported 26 potential cases of bleeding and clotting after the administration of Covishield vaccine.

India , Union-health-ministry , National-adverse-event-following-immunization , Ministry-of-health , Health-ministry , Family-welfare , Health-care-workers , Vaccine-beneficiaries , Bleeding , Lotting , Ovishield-vaccine

Existing online bookings for Covishield second dose will not be cancelled: Govt

Highlights
Those with an appointment for the second dose of the virus will not be turned away at centres
The Centre had on May 13 extended the gap between the first and second doses of Covishield vaccine
New Delhi: The Union health ministry on Sunday (May 16) clarified that already booked online appointments for the second dose of Covishield vaccine will remain valid and the same will not be cancelled on the Co-WIN platform.
It also mentioned that requisite changes have now been done in the Co-WIN digital portal, as a result of which further online or on-site appointments will not be possible if the period after first dose date for a beneficiary is less than 84 days.

India , New-delhi , Delhi , Serum-institute-of-india , Serum-institute , Covid-19 , Oronavirus , Ovishield-vaccine , இந்தியா , புதியது-டெல்ஹி , டெல்ஹி

DNA Explainer: What happens if you take one shot of Covaxin and the other of Covishield?

DNA Explainer: What happens if you take one shot of Covaxin and the other of Covishield?
A frequent question arises is that can one take Covaxin as a second shot if you have taken Covishield for the first short and vice versa?
(Image Source: Reuters)
Updated: May 15, 2021, 03:58 PM IST
Amid the second wave of the COVID-19 pandemic, India has started the third phase of its vaccination drive across the country. Since this is a new disease and the vaccine to prevent it has been made in a record time, people have their own hesitations and doubts about it.
As of now, the Indian government had given nod to two vaccines - AstraZeneca's Covishield and Bharat Biotech's Covaxin. Only recently Russian Sputnik V vaccine has received clearance in India.

Uttar-pradesh , India , Russia , Maharajganj , Bihar , Russian , Bharat , Oxford-astrazeneca , Covishield-astrazeneca , Gaurav-singh-sogarwal , Astrazeneca-covishield , Pfizer

'Extended gap between 2 doses of Covishield reasonable approach,' says US advisor Dr Fauci

'Extended gap between 2 doses of Covishield reasonable approach,' says US advisor Dr Fauci - "The fact that you delay it that long, it is very unlikely that it would have a negative effect on the efficacy of the vaccine," Fauci said.

New-york , United-states , India , White-house , District-of-columbia , Los-angeles , Anthony-fauci , Department-of-defense , Sputnikv-vaccine , United-state-that , Dr-fauci , Ovishield-vaccine-dose-gap

The Gap Between Two Vaccine Doses Increased in India, Shortage The Reason?

The Gap Between Two Vaccine Doses Increased in India, Shortage The Reason?
May 14, 2021, 11:24 IST
The Central government on Thursday decided to extend the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-6 weeks.
Meanwhile, the gap between Covaxin doses remains unchanged. As the gap between two doses of Covaxin remains 28-42 days.
The government said in its statement that based on available real-life evidence, particularly from the United Kingdom, the COVID-19 Working Group has agreed to increase the dosing interval between two doses of Covishield to 12-16 weeks. No change in intervals for Covaxin was recommended.

India , United-kingdom , National-expert-group-on-vaccine-administration , Covishield-vaccine , His-tweet-here , National-expert-group , Vaccine-administration , Covishield-vaccine-news , Ovishield-vaccination-gap , Ovishield-vaccination-news , Ovishield-vaccination-upadates

COVID-19: Government panel recommends 12-16 week gap between Covishield doses, no changes for Covaxin

COVID-19: Government panel recommends 12-16 week gap between Covishield doses, no changes for Covaxin
The National Immunization Technical Advisory Group said pregnant women can choose their vaccine and lactating women will also be eligible for vaccine.
(Image Source: File Photo)
Updated: May 13, 2021, 12:51 PM IST
The National Immunization Technical Advisory Group has suggested that the gap between two doses of the Covishield vaccine can be increased to 12-16 weeks. However, the government panel did not recommend any changes in dosage interval for Covaxin, the second of two vaccines in use in India.
The Hyderabad-based Bharat Biotech's indigenously developed Covaxin and Oxford-AstraZeneca's Covishield are currently being used in India's inoculation drive against the COVID-19 virus.

India , National-immunization-technical-advisory-group , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunisation , National-technical-advisory-group , National-expert-group , Vaccine-administration , Covid-19-pandemic , Ovid-19-second-wave , Ovid-19-vaccine-above-18 , Accine-doses